According to the report Asia Pacific Preclinical in-vivo imaging Industry, published by Market Data Forecast, The Industry has been estimated at USD 119.20 Million in 2016 and is projected to reach USD 174.50 Million by 2021, at a CAGR of 7.92% during the forecast period from 2016 to 2021.
- Advertising -
In-vivo imagers, also called as preclinical imaging systems, are imaging systems that look deep into the tissues of living subjects. The benefits of this type of system are that it gives the most complete picture of the biological effects of a treatment or disease progression and the animal is kept alive allowing future analysis on the same subject.
Browse Industry data tables and in-depth TOC of the Asia Pacific Preclinical In-vivo Imaging Industry to 2021 @ www.marketdataforecast.com/market-…aging-market-585/
In Asia-Pacific region, factors like growing acceptance of preclinical imaging as a legitimate drug development tool and technological advancements in molecular imaging modalities are helping in the growth of the Industry. However, challenges associated with the application of radioisotopes, such as short half-life of PET radioisotopes restricts the demand for micro-PET systems in developing Asian countries.
- Advertising -
Asia Pacific Industry for Preclinical In-vivo Imaging is segmented based on Modality and Reagents. Based on modality, the Asia-Pacific preclinical imaging Industry is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems.
The preclinical optical imaging systems Industry includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems Industry comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and tri-modality (PET/SPECT/CT) imaging systems.
Bases on the reagents, the Asia-Pacific preclinical imaging Industry is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents Industry is further sub-segmented as bioluminescent and fluorescent imaging reagents.
Likewise, the nuclear imaging reagents Industry is divided as preclinical PET tracers and SPECT probes.
Free sample of the report is available @ www.marketdataforecast.com/market-…85/request-sample
Geographically, Asia Pacific Industry for Preclinical In-vivo Imaging is segmented into China, Japan, India, South Korea and Australia. Increased government funding for development of pharmaceutical industry and rising R&D activities by big pharma and biotech companies, are attracting the companies to invest in the countries of Asia-Pacific region.
Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the Asia-Pacific preclinical imaging systems Industry.
Inquire report @ www.marketdataforecast.com/market-…arket-585/inquire
Key Points from Table of Contents
- Executive Summary
- Key Inferences
- New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Asia Pacific Preclinical In-vivo Imaging Industry: Segmentation
- By Modality
- o Optical imaging
- o Nuclear imaging
- o Micro-MRI
- o Micro-CT
- o Micro-ultrasound
- o Photoacoustic
- o Magnetic particle imaging systems
- By Reagent
- o Optical imaging reagents
- o Nuclear imaging reagents
- o MRI contrast agents
- o Ultrasound contrast agents
- o CT contrast agents
- South Korea
- PESTLE analysis
- Porter’s Five analysis
Industry Leaders' Analysis
Avail report @ www.marketdataforecast.com/market-…/request-discount
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: